Aqua Bio Technology ASA ( (DE:3FZ) ) just unveiled an update.
Aqua Bio Technology ASA announced that it will not prepare a separate quarterly report for Q4 2024 and will submit its annual financial statements by April 30, 2025. Preliminary estimates indicate a significant negative result due to operating losses and impairments from a subsidiary’s bankruptcy, prompting restructuring efforts aimed at achieving a positive EBITDA in 2025. The company forecasts a consolidated revenue exceeding MNOK 500 for 2025, reflecting conservative growth due to revenue recognition differences and incomplete acquisitions in 2024.
More about Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is engaged in the development and commercialization of sustainable biotechnology for skincare products. The company provides the cosmetics industry with natural alternatives to traditional ingredients and also markets and distributes natural skincare products developed by partners to both consumers and professional users. ABT is listed on Euronext Expand.
YTD Price Performance: 36.47%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €26.92M
For detailed information about 3FZ stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com